Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Biochemical and renal function parameters in the different groups of rats. Creatinine clearance, serum phosphate, PTH (1 to 84), PTH (1 to 34), calcium, FGF23, and calcitriol. Data are represented as median [interquartile range (IQR)]. n, number of rats. a p < 0.05, aa p < 0.01, aaa p < 0.001 versus SHAM NP; bb p < 0.01, bbb p < 0.001 versus SHAM HP; c p < 0.05, cc p < 0.01, ccc p < 0.001 versus PTX NX NP; d p < 0.05, dd p < 0.01, ddd p < 0.001 versus PTX NX HP; ee p < 0.01 versus NX NP. | SHAM NP | SHAM HP | PTX NX NP | PTX NX HP | NX NP | NX HP: Serum Calcitriol (pg/mL) (median [IQR]) | 5.00 [5.00, 5.15] | 14.90 [12.65, 18.05] aaa | 5.00[5.00, 5.00] | 5.00[5.00, 5.00] bbb | 5.00 [5.00, 5.00] | 10.26 [8.08, 12.22] addee

Source: Results table. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Mixed research settings

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

The rats were housed in wire cages with unrestricted access to food and water.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

RANKL, but Not R-Spondins, Is Involved in Vascular Smooth Muscle Cell Calcification through LGR4 Interaction

Study design awaiting verification · International Journal of Molecular Sciences · 2024

Original publication title

RANKL, but Not R-Spondins, Is Involved in Vascular Smooth Muscle Cell Calcification through LGR4 Interaction

Sara Fernández-Villabrille; Julia Martín-Vírgala; Beatriz Martín-Carro; Francisco Baena-Huerta; Nerea González-García; Helena Gil-Peña; Minerva Rodríguez-García; Jesús María Fernández-Gómez; José Luis Fernández-Martín; Cristina Alonso-Montes; Manuel Naves-Díaz; Natalia Carrillo-López; Sara Panizo

© 2024 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Vascular calcification has a global health impact that is closely linked to bone loss. The Receptor Activator of Nuclear Factor Kappa B (RANK)/RANK ligand (RANKL)/osteoprotegerin (OPG) system, fundamental for bone metabolism, also plays an important role in vascular calcification. The Leucine-rich repeat-containing G-protein-coupled receptor 4 (LGR4), a novel receptor for RANKL, regulates bone remodeling, and it appears to be involved in vascular calcification. Besides RANKL, LGR4 interacts with R-spondins (RSPOs), which are known for their roles in bone but are less understood in vascular calcification.

Studies were conducted in rats with chronic renal failure fed normal or high phosphorus diets for 18 weeks, with and without control of circulating parathormone (PTH) levels, resulting in different degrees of aortic calcification. Additionally, vascular smooth muscle cells (VSMCs) were cultured under non-calcifying (1 mM phosphate) and calcifying (3 mM phosphate) media with different concentrations of PTH. To explore the role of RANKL in VSMC calcification, increasing concentrations of soluble RANKL were added to non-calcifying and calcifying media. The effects mediated by RANKL binding to its receptor LGR4 were investigated by silencing the LGR4 receptor in VSMCs.

Furthermore, the gene expression of the RANK/RANKL/OPG system and the ligands of LGR4 was assessed in human epigastric arteries obtained from kidney transplant recipients with calcification scores (Kauppila Index). Increased aortic calcium in rats coincided with elevated systolic blood pressure, upregulated Lgr4 and Rankl gene expression, downregulated Opg gene expression, and higher serum RANKL/OPG ratio without changes in Rspos gene expression. Elevated phosphate in vitro increased calcium content and expression of Rankl and Lgr4 while reducing Opg. Elevated PTH in the presence of high phosphate exacerbated the increase in calcium content.

No changes in Rspos were observed under the conditions employed. The addition of soluble RANKL to VSMCs induced genotypic differentiation and calcification, partly prevented by LGR4 silencing. In the epigastric arteries of individuals presenting vascular calcification, the gene expression of RANKL was higher. While RSPOs show minimal impact on VSMC calcification, RANKL, interacting with LGR4, drives osteogenic differentiation in VSMCs, unveiling a novel mechanism beyond RANKL-RANK binding.

Authors’ abstract

Vascular calcification has a global health impact that is closely linked to bone loss. The Receptor Activator of Nuclear Factor Kappa B (RANK)/RANK ligand (RANKL)/osteoprotegerin (OPG) system, fundamental for bone metabolism, also plays an important role in vascular calcification. The Leucine-rich repeat-containing G-protein-coupled receptor 4 (LGR4), a novel receptor for RANKL, regulates bone remodeling, and it appears to be involved in vascular calcification. Besides RANKL, LGR4 interacts with R-spondins (RSPOs), which are known for their roles in bone but are less understood in vascular calcification.

Studies were conducted in rats with chronic renal failure fed normal or high phosphorus diets for 18 weeks, with and without control of circulating parathormone (PTH) levels, resulting in different degrees of aortic calcification. Additionally, vascular smooth muscle cells (VSMCs) were cultured under non-calcifying (1 mM phosphate) and calcifying (3 mM phosphate) media with different concentrations of PTH. To explore the role of RANKL in VSMC calcification, increasing concentrations of soluble RANKL were added to non-calcifying and calcifying media. The effects mediated by RANKL binding to its receptor LGR4 were investigated by silencing the LGR4 receptor in VSMCs.

Furthermore, the gene expression of the RANK/RANKL/OPG system and the ligands of LGR4 was assessed in human epigastric arteries obtained from kidney transplant recipients with calcification scores (Kauppila Index). Increased aortic calcium in rats coincided with elevated systolic blood pressure, upregulated Lgr4 and Rankl gene expression, downregulated Opg gene expression, and higher serum RANKL/OPG ratio without changes in Rspos gene expression. Elevated phosphate in vitro increased calcium content and expression of Rankl and Lgr4 while reducing Opg. Elevated PTH in the presence of high phosphate exacerbated the increase in calcium content.

No changes in Rspos were observed under the conditions employed. The addition of soluble RANKL to VSMCs induced genotypic differentiation and calcification, partly prevented by LGR4 silencing. In the epigastric arteries of individuals presenting vascular calcification, the gene expression of RANKL was higher. While RSPOs show minimal impact on VSMC calcification, RANKL, interacting with LGR4, drives osteogenic differentiation in VSMCs, unveiling a novel mechanism beyond RANKL-RANK binding.

Publication and source details

Original title: RANKL, but Not R-Spondins, Is Involved in Vascular Smooth Muscle Cell Calcification through LGR4 Interaction

Sara Fernández-Villabrille; Julia Martín-Vírgala; Beatriz Martín-Carro; Francisco Baena-Huerta; Nerea González-García; Helena Gil-Peña; Minerva Rodríguez-García; Jesús María Fernández-Gómez; José Luis Fernández-Martín; Cristina Alonso-Montes; Manuel Naves-Díaz; Natalia Carrillo-López; Sara Panizo

International Journal of Molecular Sciences · 2024

* Correspondence: cristina.alonso@ispasturias.es (C.A.-M.); manuelluis.naves@sespa.es (M.N.-D.)
†

Equal contribution as first authors.

‡

Equal contribution as senior authors.

© 2024 by the authors.2024https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).Instituto de Salud Carlos IIICP23/00105CP23/00058PI20/00753PI20/00633PI22/00195Instituto de Salud Carlos IIIEuropean UnionPI23/00833ISCIII Retic REDinRENRD16/0009/0017ISCIII Red de Investigación Cooperativa Orientada a Resultados en SaludRD21/0005/0019RD21/0005/0011Plan Estatal de I + D + I 2013 to 2016, Plan de Ciencia, Tecnología e Innovación 2013 to 2017 y 2018 to 2022 del Principado de AsturiasGRUPIN14-028IDI-2018-000152IDI/2021/000080Fundación Renal Iñigo Álvarez de Toledo (FRIAT)This study was funded by Instituto de Salud Carlos III (ISCIII, CP23/00105; CP23/00058; PI20/00753, PI20/00633, PI22/00195, and PI23/00833 co-funded by the European Union), the ISCIII Retic REDinREN (RD16/0009/0017), the ISCIII Red de Investigación Cooperativa Orientada a Resultados en Salud RICORS2040 (RD21/0005/0019 and RD21/0005/0011, Next Generation EU; Recovery, Transformation and Resilience Plan), Plan Estatal de I + D + I 2013 to 2016, Plan de Ciencia, Tecnología e Innovación 2013 to 2017 y 2018 to 2022 del Principado de Asturias (GRUPIN14-028, IDI-2018-000152, IDI/2021/000080) and, Fundación Renal Iñigo Álvarez de Toledo (FRIAT). S.F.-V. and B.M.-C. were supported by a graduate fellowship from the Gobierno del Principado de Asturias (“Severo Ochoa” program: BP20-081 and BP19-057 respectively). J.M.-V. and N.G.-G were supported by a graduate fellowship from the Ministerio de Ciencia, Innovación y Universidades (FPU program: FPU2019-00483 and PFIS program: FI23/00007, respectively). F.B.-H. was supported by the additional funding granted under CP23/00105. C.A.-M. was supported by Fundación para la Investigación Biosanitaria de Asturias (FINBA). N.C.-L. and S.P. were supported by ISCIII: Miguel Servet Program (CP23/00058; CP23/00105).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T11:20:11.267459+00:00

DOI: 10.3390/ijms25115735 · PMC11172097